Clinical Trial

BCAAs in Concussion 2.0

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated May 27, 2026 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is a randomized, placebo-controlled, double-blinded, therapeutic exploratory clinical trial of branched chain amino acids (BCAAs) in the treatment of concussion. The aim of the study is to determine whether administration of high-dose BCAAs compared to placebo promotes concussion recovery.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-02-13; most recent amendment 2026-05-22.
Status change: Recruiting → Active, Not Recruiting 2026-05-22
Status change: Not Yet Recruiting → Recruiting 2025-04-30
Trial Details
NCT Number NCT06829498
Lead Sponsor Akiva Cohen
Conditions Concussion, Brain, Concussion, Mild, Concussion
Enrollment 17 participants
Start Date 2025-04-01
Primary Completion 2026-08-01 (estimated)
Study Completion 2026-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-27